Household net worth linked to hormonal therapy adherence among patients with breast cancer
the ONA take:
According to a recent study published in the Journal of Clinical Oncology, researchers from the Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Medical Center in New York City have found that household net worth is a major factor in adherence to hormonal therapy among patients with breast cancer that is often overlooked, possibly explaining racial disparities in quality of care.
In order to study the effect of household net worth on quality of care in patients with breast cancer, the researchers analyzed financial and prescription data on 2,437 women aged 50 years and older with early-stage breast cancer who had been prescribed aromatase inhibitors, such as anastrozole or letrozole, between 2007 and 2011. Results showed that income and net worth were directly associated with medication adherence.
The authors note that the findings suggest that healthcare professionals, health insurers, and policy makers need to consider this economic variable so that patients with breast cancer can receive potentially life-saving treatment.
Healthcare providers must engage their patients in a conversation about whether they will be able to afford their medications, so that a solution can be determined to reduce non-adherence and improve outcomes.
Household net worth is a major factor in adherence to hormonal therapy among patients with breast cancer.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|